LONG-ACTING RISPERIDONE INJECTION: EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF THE FIRST LONG-ACTING ATYPICAL ANTIPSYCHOTIC - Pierre Chue

Vizualizeaza articolul complet in format PDF

Sponsori si parteneri